Kova
Kova publishes 8 rankable monthly figures and not one of them says what dose it buys. This site prints no comparable figure for Kova, and the reading behind that is on this page.
Ellis Brandt built this site’s grading methodology and maintains it. Last re-read September 2026.
The figures this seller publishes
Kova publishes 8 rankable monthly figures for semaglutide and tirzepatide. This site prints no comparable figure for Kova, because a figure that does not say what dose it buys cannot be compared with one that does. What follows is what was read, in the words of the person who read it.
Semaglutide — reading 1 of 4
The seller ties no dose to this figure.
No mg appears anywhere in this page's visible text and Kova makes no flat-price claim, so there is nothing to tie this figure to a dose. The FAQ question 'Can my provider change my dosage during treatment?' is a collapsed accordion with no visible answer. Note: The plan table sits behind a Semaglutide/Tirzepatide toggle whose two sides print identical prices, so the molecule comes from the page URL, not from the window. This is the 12-month-commitment rate.
The page says the figure covers consultation, provider follow-up, medication fulfillment coordination. Read September 2026 from https://trykova.com/semaglutide.
Semaglutide — reading 2 of 4
The seller ties no dose to this figure.
No mg appears anywhere in this page's visible text and Kova makes no flat-price claim, so there is nothing to tie this figure to a dose. The FAQ question 'Can my provider change my dosage during treatment?' is a collapsed accordion with no visible answer. Note: The plan table sits behind a Semaglutide/Tirzepatide toggle whose two sides print identical prices, so the molecule comes from the page URL, not from the window. This is the 6-month-commitment rate.
The page says the figure covers consultation, provider follow-up, medication fulfillment coordination. Read September 2026 from https://trykova.com/semaglutide.
Semaglutide — reading 3 of 4
The seller ties no dose to this figure.
No mg appears anywhere in this page's visible text and Kova makes no flat-price claim, so there is nothing to tie this figure to a dose. The FAQ question 'Can my provider change my dosage during treatment?' is a collapsed accordion with no visible answer. Note: The plan table sits behind a Semaglutide/Tirzepatide toggle whose two sides print identical prices, so the molecule comes from the page URL, not from the window. This is the 3-month-commitment rate.
The page says the figure covers consultation, provider follow-up, medication fulfillment coordination. Read September 2026 from https://trykova.com/semaglutide.
Semaglutide — reading 4 of 4
The seller ties no dose to this figure.
No mg appears anywhere in this page's visible text and Kova makes no flat-price claim, so there is nothing to tie this figure to a dose. The FAQ question 'Can my provider change my dosage during treatment?' is a collapsed accordion with no visible answer. Note: The plan table sits behind a Semaglutide/Tirzepatide toggle whose two sides print identical prices, so the molecule comes from the page URL, not from the window. This is the month-to-month renewal rate after a $249 first month.
The page says the figure covers consultation, provider follow-up, medication fulfillment coordination. Read September 2026 from https://trykova.com/semaglutide.
Tirzepatide — reading 1 of 4
The seller ties no dose to this figure.
Kova's tirzepatide page prints no mg anywhere in its visible text (the capture header records 'mg DOSES VISIBLE ANYWHERE ON THIS PAGE: NONE'). The plan table is a term ladder (1/3/6/12-month), not a dose ladder, so there is nothing to pair $129 with. A FAQ heading 'Can my provider change my dosage during treatment?' is printed with no visible answer.
The page says the figure covers consultation, provider follow-up. Read September 2026 from https://trykova.com/tirzepatide.
Tirzepatide — reading 2 of 4
The seller ties no dose to this figure.
Same page as offer 1476: no mg is printed anywhere in the visible text, so $149/mo (6-Month Plan) cannot be tied to any dose. The only ladder on the page is a commitment-length ladder.
The page says the figure covers consultation, provider follow-up. Read September 2026 from https://trykova.com/tirzepatide.
Tirzepatide — reading 3 of 4
The seller ties no dose to this figure.
No mg appears anywhere in this page's visible text, so the $179/mo 3-Month Plan figure has no dose to attach to.
The page says the figure covers consultation, provider follow-up. Read September 2026 from https://trykova.com/tirzepatide.
Tirzepatide — reading 4 of 4
The seller ties no dose to this figure.
No mg is printed anywhere on this page's visible text. $299/mo is the renewal rate after the $249 first month; nothing on the page ties any figure to a dose.
The page says the figure covers consultation, provider follow-up. Read September 2026 from https://trykova.com/tirzepatide.
What the page states, and what it leaves out
Talks about pharmacies and names none. No figure this seller publishes states what it buys, so no price is printed here.
Cancellation
Cancellation terms have not been read for Kova. The pass that opened, timed and recorded cancellation terms covered the 60 sellers whose figure states what it buys, and Kova is not one of them. This site therefore states nothing about how Kova handles cancellation — not that terms are absent, only that we have not read them. It is a gap in this site’s reading, and it is recorded as one rather than scored as a silence.
Dose escalation
This seller does not print the titration steps its patients follow. 54 of the 60 sellers whose figure states what it buys do not either. What the four FDA-approved labels set as the escalation is published on this site with no provider named and no paid link.
Go to Kova
Kova pays this site nothing. The link below is unpaid and carries no tracking of any kind. It goes to the page that carries the figure quoted above.
Visit siteWhere this seller is listed
One board per buying decision. Each is the same table with the columns that decision needs, under its own dated and counted title.
- Semaglutide providers54 listed, September 2026
Readers who have settled on semaglutide and are choosing who to buy it from.
- Tirzepatide providers52 listed, September 2026
Readers who have settled on tirzepatide and are choosing who to buy it from.
- Providers that publish a price before the intake59 listed, September 2026
Readers who will not start an intake without seeing a standing rate and what it covers.
- GLP-1 providers with a published price, compared59 listed, September 2026
Readers whose first question is the number, and who want to see what each figure actually buys before comparing them.
- GLP-1 providers for readers paying cash52 listed, September 2026
Readers who are paying out of pocket and need the medication itself inside the published figure, not just the consult.
- GLP-1 telehealth providers60 listed, September 2026
Readers choosing a prescriber rather than a price — who dispenses, what the plan includes, and how to leave it.